Clinical Trials Browser

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

NCT02574728 2026-03-02

AflacST1502

Brain Neoplasms, Carcinoma, Ependymoma, Histiocytosis, Langerhans-Cell, Medulloblastoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neuroblastoma, Pinealoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

NCT07428993 2026-02-24

Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma

Phase 2 Not yet recruiting

41 enrolled

Sarcoma

Osteosarcoma

NCT07321912 2026-01-08

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Phase 2 Not yet recruiting

406 enrolled

Sarcoma

Sarcoma, Ewing, Osteosarcoma

NCT03063983 2017-03-13

GLATO2017

Phase 2 Unknown

158 enrolled

Sarcoma

Neoplasm Metastasis, Osteosarcoma

NCT00743509 2015-09-28

OCR

Phase 2 Completed

49 enrolled 7 charts

Sarcoma

Neoplasm Metastasis, Recurrence, Sarcoma, Osteosarcoma

NCT00002466 2013-06-20

Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer

Phase 2 Completed

GenitourinarySarcoma

Askin Tumor, Kidney Neoplasms, Wilms Tumor, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Clinical Trials

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

AflacST1502

Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

GLATO2017

OCR

Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer